FPHAX vs. PHSTX
Compare and contrast key facts about Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Putnam Global Health Care Fund (PHSTX).
FPHAX is managed by Fidelity. It was launched on Jun 17, 2001. PHSTX is managed by Putnam. It was launched on May 27, 1982.
Performance
FPHAX vs. PHSTX - Performance Comparison
Loading graphics...
FPHAX vs. PHSTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | -2.56% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
PHSTX Putnam Global Health Care Fund | -5.20% | 15.20% | 1.35% | 9.11% | -4.88% | 19.60% | 15.94% | 30.26% | -0.76% | 15.30% |
Returns By Period
In the year-to-date period, FPHAX achieves a -2.56% return, which is significantly higher than PHSTX's -5.20% return. Over the past 10 years, FPHAX has outperformed PHSTX with an annualized return of 10.94%, while PHSTX has yielded a comparatively lower 8.86% annualized return.
FPHAX
- 1D
- 0.57%
- 1M
- -9.52%
- YTD
- -2.56%
- 6M
- 15.21%
- 1Y
- 27.23%
- 3Y*
- 16.20%
- 5Y*
- 11.88%
- 10Y*
- 10.94%
PHSTX
- 1D
- 0.66%
- 1M
- -9.12%
- YTD
- -5.20%
- 6M
- 5.37%
- 1Y
- 3.92%
- 3Y*
- 7.27%
- 5Y*
- 6.39%
- 10Y*
- 8.86%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FPHAX vs. PHSTX - Expense Ratio Comparison
FPHAX has a 0.75% expense ratio, which is lower than PHSTX's 1.05% expense ratio.
Return for Risk
FPHAX vs. PHSTX — Risk / Return Rank
FPHAX
PHSTX
FPHAX vs. PHSTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Putnam Global Health Care Fund (PHSTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FPHAX | PHSTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.14 | 0.24 | +0.89 |
Sortino ratioReturn per unit of downside risk | 1.61 | 0.45 | +1.17 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.06 | +0.15 |
Calmar ratioReturn relative to maximum drawdown | 2.05 | 0.35 | +1.70 |
Martin ratioReturn relative to average drawdown | 5.99 | 0.82 | +5.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FPHAX | PHSTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 0.24 | +0.89 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.67 | 0.45 | +0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 0.56 | +0.05 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.61 | -0.08 |
Correlation
The correlation between FPHAX and PHSTX is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FPHAX vs. PHSTX - Dividend Comparison
FPHAX's dividend yield for the trailing twelve months is around 5.83%, more than PHSTX's 1.88% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.83% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
PHSTX Putnam Global Health Care Fund | 1.88% | 1.79% | 4.92% | 5.62% | 7.82% | 11.98% | 9.58% | 5.72% | 6.82% | 17.31% | 10.65% | 13.06% |
Drawdowns
FPHAX vs. PHSTX - Drawdown Comparison
The maximum FPHAX drawdown since its inception was -38.26%, smaller than the maximum PHSTX drawdown of -45.51%. Use the drawdown chart below to compare losses from any high point for FPHAX and PHSTX.
Loading graphics...
Drawdown Indicators
| FPHAX | PHSTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.26% | -45.51% | +7.25% |
Max Drawdown (1Y)Largest decline over 1 year | -11.00% | -10.02% | -0.98% |
Max Drawdown (5Y)Largest decline over 5 years | -28.82% | -20.71% | -8.11% |
Max Drawdown (10Y)Largest decline over 10 years | -28.82% | -25.51% | -3.31% |
Current DrawdownCurrent decline from peak | -9.82% | -9.12% | -0.70% |
Average DrawdownAverage peak-to-trough decline | -9.21% | -9.93% | +0.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.35% | 4.74% | -0.39% |
Volatility
FPHAX vs. PHSTX - Volatility Comparison
Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 6.10% compared to Putnam Global Health Care Fund (PHSTX) at 4.25%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than PHSTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FPHAX | PHSTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 4.25% | +1.85% |
Volatility (6M)Calculated over the trailing 6-month period | 14.17% | 9.95% | +4.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.39% | 16.72% | +6.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.69% | 14.21% | +3.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.78% | 15.79% | +1.99% |